$CNXC

Why Concentrix (CNXC) Stock Is Up Today

Concentrix (CNXC) stock rose 4% after reporting a Q3 net loss of $988.1M, driven by a $1.5B goodwill impairment charge. Revenue fell 1.2% YoY to $2.45B, missing estimates. Adjusted EPS was $2.92. The company cited AI deployments and client decisions for the decline. Shares later cooled to $25.73, up 1%.

Original reporting
Published Sep 30, 2026, 2:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 3:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Concentrix (CNXC) Stock Is Up Today — source image
Decision brief

The 30-second read

$CNXCBearishLow
01

Why it matters

Earnings miss and impairment are likely to weigh on the stock despite the brief rally, with investors focusing on profitability and margin pressure.

02

Market read

The earnings release provides fresh, material data that could influence trading decisions on CNXC and peers in the services sector.

03

What to watch

Adjusted free cash flow hit a record $218.3M and operating margin expanded, indicating underlying cash generation strength.

Relevance 7/10Novelty 8/10Timing: intraday today

Background

Concentrix reported a Q3 net loss driven by a $1.5B goodwill impairment and slight revenue decline, while adjusted free cash flow reached a record.

Company-level read

Ticker impact

$CNXCBearishHigh confidence
Context

Q3 earnings disclosed a $988.1M net loss and a $1.5B goodwill impairment, causing a 4% intraday price jump.

Expected impact

likely pressure as investors price in the sizable loss and impairment.

Evidence & confidence

Earnings are the first report of the loss; the magnitude of the impairment is material and the stock already showed volatility.

Market effects

Highlights risk in the customer experience services sector, especially regarding AI deployment and offshore delivery trends.

U.S. tech services stocks may see heightened scrutiny after the loss.

Limited to investors tracking U.S. mid‑cap service providers.

Counterpoint

The 4% pop suggests short‑term buying interest; the stock may rebound if the market overreacts to the loss.

Key entities

  • Concentrix

    Customer experience solutions provider reporting Q3 results.

  • Christopher Caldwell

    President and CEO who commented on AI deployment and client shifts.

  • Andre Valentine

    CFO who discussed offshore delivery headwinds.

Related articles

$CNXCHighAI 8/10

Concentrix earnings analysis: questions answered and next catalysts

Concentrix Corp (CNXC) reported Q3 earnings with a $0.21 EPS beat ($2.92) but a $30M revenue miss ($2.45B vs. $2.48B est). Shares initially dropped 9.77% before recovering 3.12%. Management highlighted AI-driven revenue growth (50% of total) and cash flow strength ($218M), but revenue declines due to specific client exits and offshoring. The dividend was raised to $0.37/share. Growth is expected to return in 2028, with key catalysts including Q4 earnings and debt paydown milestones.

$CNXCMedAI 8/10

Why Concentrix Stock Ended Up Moving Higher Today

Concentrix (CNXC) reported fiscal Q3 revenue below estimates due to client shifts, but earnings beat expectations. CEO Christopher Caldwell attributed the shortfall to client preferences, not customer loss. The stock initially dropped but recovered, up 3% by midday. Analysts' average price target is $33.50, over 30% above current levels.

$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

$CNXCHighAI 8/10

Concentrix Posts Mixed Q3 Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday’s

Concentrix Corp (NASDAQ:CNXC) shares fell 10.6% premarket after reporting mixed Q3 results, missing sales estimates and issuing weak Q4 guidance. The company also narrowed its FY26 adjusted EPS guidance and cut FY26 sales guidance below estimates. Earnings of $2.92 per share beat estimates, while sales of $2.454 billion missed expectations.

$BAMed

Stocks making the biggest moves premarket: Robinhood, Boeing, Moderna & more

Boeing shares rose 2% after securing a $20B defense contract. Robinhood gained 2% with new AI features and 24/7 trading plans. Concentrix dropped 9.5% on weak earnings and guidance. Moderna fell 6% after a Citi downgrade. FormFactor rose 1% on a Deutsche Bank buy rating. Cal-Maine Foods declined 6.5% on larger-than-expected losses.

$CNXCHighAI 8/10

Concentrix (CNXC) Q3 2026 Earnings Call Transcript

Concentrix (CNXC) reported Q3 2026 revenue of $2.45B, down 1.2%, with non-GAAP EPS at $2.92, up $0.14 YoY. Non-GAAP operating income exceeded guidance, but GAAP net loss was $988.1M due to a $1.05B goodwill impairment charge. Q4 revenue guidance is $2.41B-$2.46B, with FY 2026 revenue expected at $9.827B-$9.877B. Management highlighted AI-driven growth and debt reduction plans.